Asembia Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture and Meet Compliance Requirements
HITRUST CSF Certification validates Asembia is committed to meeting key regulations and protecting sensitive information
Sep 24, 2018, 10:37 ET
FLORHAM PARK, N.J., Sept. 24, 2018 /PRNewswire/ -- Asembia, a leading provider of collaborative solutions and group purchasing services to the specialty pharmacy industry, today announced the company's Asembia-1 specialty pharmacy workflow platform has earned Certified status for information security by HITRUST.
HITRUST CSF Certified status demonstrates that the organization's Asembia-1 system and supporting infrastructure has met key regulatory requirements and industry-defined requirements and is appropriately managing risk. This achievement places Asembia in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.
"Organizations, like ours, are under great pressure to meet complex compliance requirements that include technical and process elements such as HIPAA, NIST, ISO and COBIT," said Anthony Marconi, EVP of operations. "The HITRUST CSF is the gold-standard that needs to be met, and Asembia is pleased to be able to demonstrate its commitment by achieving HITRUST CSF Certification."
"HITRUST has been working with the industry to ensure the appropriate information protection requirements are met when sensitive information is accessed or stored in a cloud environment," said Ken Vander Wal, Chief Compliance Officer, HITRUST. "We are pleased that Asembia has taken the steps necessary to achieve HITRUST CSF Certified status, and we expect their customers to have confidence in this designation."
About Asembia
For more than a decade, Asembia has been working with member pharmacies, manufacturers, prescribers, payers, and other industry stakeholders to develop solutions for the high-touch specialty pharmaceutical service model. Through collaborative programs, contracting initiatives, patient support HUB services and innovative technology platforms, Asembia is committed to providing solutions that impact the patient journey. For more information, visit www.asembia.com.
Contact:
Portia Levasseur
Associate Director, Marketing
Asembia
P: 973.564.8004
E: [email protected]
SOURCE Asembia
